Enforcement Report - Week of November 6, 2024
06 Nov 2024 //
FDA
Accord Healthcare Receives Positive CHMP Opinion for Imuldosa
19 Oct 2024 //
PR NEWSWIRE
Enforcement Report - Week of July 10, 2024
10 Jul 2024 //
FDA
Accord Healthcare restarts production of cancer drug cisplatin
16 Nov 2023 //
FIERCE PHARMA
Accord Healthcare`s Degarelix Accord (degarelix) Receives Approval in Europe
08 Nov 2023 //
EMA
Accord resumes production of cancer drug methotrexate amid supply shortage
07 Nov 2023 //
REUTERS
ACCORD and HIPRA Enter into Agreement to Commercialise COVID-19 vaccine BIMERVAX
04 Aug 2023 //
PR NEWSWIRE
Accord Healthcare`s Dabigatran Etexilate Receives Approval in the Europe
31 May 2023 //
EMA
Enforcement Report - Week of April 12, 2023
12 Apr 2023 //
FDA
Accord Healthcare Adds Generic Drug Approved for the Treatment of Relapsing MS
13 Mar 2023 //
PR NEWSWIRE
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Accord Healthcare Offers Generic Option for Treatment of Schizophrenia
21 Feb 2023 //
PR NEWSWIRE
Accord Healthcare`s Plerixafor Approved In Europe
06 Feb 2023 //
EMA
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
Accord healthcare`s Generic Fesoterodine Fumarate Receives Approval in U.S.
04 Jan 2023 //
FDA
Accord`s Generic Carmustine Receives Approval in the U.S.
27 Dec 2022 //
FDA
Accord`s Generic Bendamustine Hydrochloride Receives Approval in the U.S.
07 Dec 2022 //
FDA
Accord Healthcare Adds Generic Drug for Use in Treating Leukemia
07 Dec 2022 //
PRNEWSWIRE
Accord`s Sorafenib Receives Approval in Europe
25 Nov 2022 //
EMA
Accord`s Teriflunomide Receives Approval in Europe
14 Nov 2022 //
EMA
CPhI Pharma Awards recognise progress and innovation
02 Nov 2022 //
PHARMABIZ
Accord`s Generic Cabazitaxel Receives Approval in the U.S.
26 Oct 2022 //
FDA
Accord`s Generic Cabazitaxel Receives Approval in the U.S.
26 Oct 2022 //
FDA
Accord`s Generic Metoprolol Succinate Receives Approval in the U.S.
18 Oct 2022 //
FDA
Accord Adds Pemetrexed Injection to Generic Chemotherapy Drug Portfolio
13 Sep 2022 //
PRNEWSWIRE
Accord`s Generic Clobazam Receives Approval in the U.S.
06 Sep 2022 //
FDA
Accord Healthcare Launches Generic Drug for Brain Tumors & Blood Cancers
23 Aug 2022 //
PRNEWSWIRE
Accord healthcare Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Accord healthcare`s Generic Lacosamide Receives Approval in the US
12 Jul 2022 //
FDA
AstraZeneca escapes 1 of 2 Seroquel pay-for-delay claims
09 Jul 2022 //
FIERCEPHARMA
Accord Healthcare Zolsketil pegylated liposomal Receives Approval in Europe
20 Jun 2022 //
EMA
Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe
17 Jun 2022 //
EMA
Accord Healthcare Sondelbay (teriparatide) Receives Approval in Europe
16 Jun 2022 //
EMA
Accord Healthcare Dasatinib Receives Approval in Europe
10 Jun 2022 //
EMA
Accord healthcare`s Generic Cabazitaxel Receives Approval in the US
08 Jun 2022 //
FDA
Accord Healthcare Releases Generic Drug Proven Effective Against IPF
01 Jun 2022 //
BIOSPACE
Accord healthcare Generic Pemetrexed Disodium Receives Approval in the U.S.
25 May 2022 //
FDA
Accord Releases Generic Drug Proven Effective Against Vitamin B12 Deficiency
19 May 2022 //
PRNEWSWIRE
Myovant and Accord Healthcare enter licence agreement to commercialise Orgovyx
13 May 2022 //
EXPRESS PHARMA
Myovant Sciences and Accord Healthcare Enter into License Agreement for ORGOVYX
09 May 2022 //
GLOBENEWSWIRE
Accord Healthcare`s Generic Regadenoson Receives Approval in the U.S.
11 Apr 2022 //
FDA
Accord BioPharma Announces New Executive Leadership
09 Mar 2022 //
PRNEWSWIRE
J&J back in court over new generic threat from Intas
19 Feb 2022 //
ENDPTS
Accord Healthcare`s Generic Pirfenidone Receives Approval in the U.S.
20 Jan 2022 //
FDA
Accord`s Generic Dextroamp Saccharate Receives Approval in the US
22 Nov 2021 //
FDA
Accord Hlthcare`s Generic Fluorouracil Receives Approval In US
14 Oct 2021 //
FDA
MHRA Class 2 Medicines Recall: Levothyroxine 50mcg tablets
27 Sep 2021 //
MHRA
Accord`s Generic Trientine Hydrochloride receives Approval in the US
30 Aug 2021 //
FDA
Accord Hlthcare`s Generic Perampanel Receives Approval In US
26 Jun 2021 //
FDA
Accord Hlthcare`s Generic Perampanel Receives Approval In US
14 Jun 2021 //
FDA
Accord Healthcare launches thalidomide for multiple myeloma treatment
23 Mar 2021 //
PHARMAFILE
Accord Hlthcare`s Generic Palonosetron Hydrochloride Receives Approval In US
23 Mar 2021 //
FDA
Camurus, Accord, Swedish Orphan Biovitrum (Sobi), Strides Pharma, BI
03 Mar 2021 //
PMCPA
Enforcement Report - Week of February 17, 2021
17 Feb 2021 //
FDA
Clinigen Expands Partnership With Accord Healthcare in Clinical Services
25 Nov 2020 //
BIOSPACE